Why we need to quit, NOW!
Tracks
4
| Saturday, August 3, 2024 |
| 12:20 PM - 1:00 PM |
| C2.5 + C2.6 |
| Sponsored By: |
Details
Tobacco smoking and vaping are the global leading cause of avoidable premature death. In Australia, smoking is responsible for 13% of deaths and 8.6% of the total disease burden. “A silent killer” responsible for multi-organ damage associated with a range of respiratory conditions including asthma and bronchitis, diabetes, heart disease, cancer and ocular diseases. Whilst vaping was once considered a ‘safer’ alternative to traditional tobacco smoking, vaping is associated with cardiovascular and respiratory complications.
Massive public health campaigns urging people to stop smoking have driven smoking rates to gradually decline in Australia. Yet smoking rates are up to five times higher in disadvantaged population groups. However, vaping rates are gradually increasing, further driving nicotine use.
So, why is it so hard to just stop smoking or vaping? Especially as the benefits of quitting smoking and vaping are tremendous; evident within hours of quitting. We need to use a multi-faceted approach is to successfully support individuals to quit smoking and vaping. Pharmacists play a critical role in supporting individuals in their quit journeys offering behavioural support and evidence-based pharmacotherapy. In this session, we will explore the common obstacles experienced by both patients and health professionals supporting the smoking cessation process. We will discuss evidence-based solutions to ideally support patients including innovative approaches to pharmacotherapy, including nicotine replacement therapy.
Learning objectives
At the end of this session, participants will be able to:
1. Outline the public health consequences of smoking and vaping.
2. Discuss common challenges experienced by both individuals and health professionals during the quit smoking process.
3. Discuss evidence-based solutions to support individuals during the quit smoking process.
Competency standards: 1.2, 1.3, 1.4, 1.5, 2.1, 3.1, 3.2, 3.5, 3.6
Speakers
Professor Kristin Carson-Chahhoud
Director/associate Research Professor And Group Lead
Houd Research Group/university Of Adelaide
Why we need to quit now!
Biography
A/Prof Kristin Carson-Chahhoud is the Managing Director of scientific & medical consulting company Houd Research Group, Lead of Translational Medicine & Technology Research Program within the Cardiovascular Pathophysiology & Therapeutics Group at the University of Adelaide, Director of Research for the Women's and Children's Hospital Respiratory Department & Associate Professor Titleholder with Adelaide University School of Medicine & UniSA's Australian Centre for Precision Health. She holds a PhD in Medicine from the University of Adelaide & Masters of Public Policy & Management from Carnegie Mellon University. Kristin is a past Board Director for the Thoracic Society of Australia and New Zealand, has served on Ministers Roundtables, & according to ExpertScape, she is within the top half a percent of global experts on smoking, having authored >130 peer reviewed publications (producing >7300 citations and a H-Index of 40), delivered >220 presentations across 7 countries (largely in tobacco control), and has attracted >$10 million in research funding. Subsequently, she has received some of the nation's most prestigious awards recognising contributions to her field, including the Eureka Prize as Australia's Emerging Leader in Science, Young Australian of the Year for South Australia, Premier's Channel 9 Young Achiever of the Year, Westpac 100 Women of Influence and 40 Under 40 Business Leaders and Entrepreneurs.
